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Abstract
Background: Several recent studies have demonstrated the effectiveness of deep sequencing for
transcriptome analysis (RNA-seq) in mammals. As RNA-seq becomes more affordable, whole
genome transcriptional profiling is likely to become the platform of choice for species with good
genomic sequences. As yet, a rigorous analysis methodology has not been developed and we are
still in the stages of exploring the features of the data.
Results: We investigated the effect of transcript length bias in RNA-seq data using three different
published data sets. For standard analyses using aggregated tag counts for each gene, the ability to
call differentially expressed genes between samples is strongly associated with the length of the
transcript.
Conclusion: Transcript length bias for calling differentially expressed genes is a general feature of
current protocols for RNA-seq technology. This has implications for the ranking of differentially
expressed genes, and in particular may introduce bias in gene set testing for pathway analysis and
other multi-gene systems biology analyses.
Reviewers: This article was reviewed by Rohan Williams (nominated by Gavin Huttley), Nicole
Cloonan (nominated by Mark Ragan) and James Bullard (nominated by Sandrine Dudoit).
Background
High throughput sequencing is likely to become the plat-
form of choice for transcriptome analysis. The ability of
sequencing platforms to interrogate the whole transcrip-
tional landscape provides new insights into the levels of
transcriptional complexity in biological systems. Tran-
script sequencing also provides novel opportunities such
as quantitatively measuring splicing variants [1] and sin-
gle nucleotide polymorphisms (SNPs) for allele specific
expression without any prior knowledge. However this
new level of detail needs careful statistical modeling to
provide the promised benefits of the new technology.
Different technologies display different data features and
will therefore have different strengths and weaknesses.
Investigation of the technical and statistical attributes of
the data will reveal the advantages and disadvantages of
each technology. We hypothesize, that using statistical
methods to detect differential expression between sam-
ples is biased by transcript length and that this bias is
inherent to the standard RNA-seq process.
Current RNA-seq protocols use an mRNA fragmentation
approach prior to sequencing to gain sequence coverage
of the whole transcript. This means, in simple terms, that
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the total number of reads for a given transcript is propor-
tional to the expression level of the transcript multiplied
by the length of the transcript. In other words a long tran-
script will have more reads mapping to it compared to a
short gene of similar expression. Since the power of an
experiment is proportional to the sampling size, there is
more power to detect differential expression for longer
genes. This is an inherent property of the data and will not
be altered by any process involving sequencing of full
length transcripts with fragments shorter than the tran-
script. By contrast, intensity measurements from microar-
rays are proportional only to the expression level of the
transcript plus any features intrinsic to the probe itself
such as GC content [2,3]. The feature of higher sampling
for longer transcripts in RNA-seq data becomes important
in situations looking at identifying differentially
expressed genes between samples. Most statistical meth-
ods for detection of differential expression will have more
power for transcripts with a larger number of reads. Short
transcripts will therefore always be at a statistical disad-
vantage relative to long transcripts in the same sample.
Here we explore several previously published datasets of
high throughput RNA sequencing and show that the most
widely used protocols for RNA-seq can detect more differ-
ential expression in longer transcripts compared to shorter
ones. This bias does not exist for microarray platforms,
which uses a single or set of diagnostic probes to assess
expression levels. We also demonstrate that the inherent
biases presented here are shown to exist in all experiments
analyzed so far independent of the specific samples, plat-
forms or statistical analysis.
Results
Based on a simplified calculation, we can show that the
ability to detect differential expression using a very simple
testing procedure depends on the length of the transcript
(see methods). To empirically investigate the effect of
transcript length bias in RNA-seq and microarrays we used
three different published data sets that sequence full
length transcripts. The first data set compares sequencing
from the Illumina Genome Analyzer with Illumina micro-
arrays and looks for differential expression between a
human embryonic kidney and B cell line [4]. The second
uses SOLiD sequencing to compare mouse embryonic
stem cells and embryoid bodies [5] and the third com-
pares Illumina sequencing with Affymetrix microarrays in
a human liver and kidney sample [6]. In order to deter-
mine which genes are differentially expressed, each study
uses a different statistical approach to calculate signifi-
cance. Here we use these statistics to examine the behavior
of differential expression with transcript length.
For each platform we first binned all genes into equal gene
number bins based on their transcript length. Next we
designated genes as differentially expressed (DE) based on
a cut-off from the statistical procedure defined in the rele-
vant publication. We found the specific statistical cut-off
used made no qualitative difference to the results. We
then calculated the percentage of DE genes for each bin.
Figure 1 shows the percentage of DE genes plotted as a
function of transcript length for both RNA-seq and micro-
arrays for each experiment. Clearly the ability to detect DE
is strongly associated with transcript length for RNA-seq
regardless of the platform, statistical analysis procedure or
overall proportion of differential expression (Figure 1a,c
and 1d). As expected no such trend is observed for the
microarray data from two different platforms (Figure 1b
and 1e).
To further investigate the transcript length bias we used
data from Marioni et al (2008) and looked at transcripts
that appear in both the RNA-seq and microarray data. We
divided the genes into three equal groups based on the
average intensity level measured on the microarrays. We
then calculated %DE as a function of length for the high
and low expression groups (Figure 1f and 1g). RNA-seq
shows an even stronger length bias for lowly expressed
genes, which is somewhat ameliorated, but still signifi-
cant, for highly expressed genes. We believe the slope is
lower in highly expressed genes because nearly all of these
genes have enough power to be called differentially
expressed in this data set even though the p-values are
higher for shorter genes. By contrast, no significant trend
is observed for highly expressed genes using the microar-
ray platform and only a slight trend is induced for genes
with low expression. Although the overall number of DE
genes called may be larger for RNA-seq, increasing the
number of replicates would increase the number of DE
genes detected by the microarrays. Careful calibration of
the absolute rates of DE between platforms could be the
subject of a further investigation, however the trends iden-
tified here scale with, and are robust to, the specific statis-
tical cut-off used.
Many of the current statistical methods use a measure of
expression level normalized by the length of the gene.
This gives an unbiased measure of the expression level but
also affects the variance of the data in a length dependent
manner resulting in the same bias to differential expres-
sion estimation (see methods for a toy example). To dem-
onstrate this effect we show the sample mean and variance
of each gene calculated from the replicate lanes of the
Marioni et al. data. In figure 2a we show that the sample
mean and variance are approximately equal as would be
expected for a Poisson random variable. However, when
the mean is divided by the length of the transcript the rela-
tionship becomes more complex and the data is no longer
Poisson. Figure 2b shows the same data with the tag
counts for each transcript divided by the length of theBiology Direct 2009, 4:14 http://www.biology-direct.com/content/4/1/14
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transcript. The two fitted curves show the mean-variance
relationship for one third of the data with the longest
transcripts and with the shortest transcripts. It is easy to
see that for genes normalized by length shorter transcripts
have larger variance for the same expression level com-
pared to longer transcripts.
The consequences of transcript length bias in RNA-seq
data becomes most problematic when comparing
between genes or sets of genes with different lengths. This
is most likely to occur when doing gene set testing in sys-
tems biology, where specific gene sets have a length bias
compared to other sets of genes. If a set contains genes
shorter than average it will appear under-represented in
differential expression whereas if the set contains genes
longer than average the category is more likely to be over-
represent in differential expression. To demonstrate this
effect we looked for over-represented KEGG pathways
using the Marioni et al RNA-seq and microarray data. In
each analysis we only used genes found on both platforms
and then performed a pathway analysis using the DAVID
software [7,8]. We found several pathways which were
over-represented for differential expression between liver
and kidney. Tables 1 and 2 show all of the pathways over-
represented below a p-value of 0.1 (however after multi-
ple testing correction only the top 16 categories remain in
the microarray data at the same significance as the
sequencing data). Categories highlighted in bold do not
appear overrepresented anywhere in the list from the
other platform. After multiple testing correction the
microarray platform contains four pathways below a
threshold of 0.1 all of which are found in the sequencing
data. By contrast the RNA-seq data contains nine catego-
ries of which three are not contained anywhere on the
array data. Figure 3 shows the lengths of the genes associ-
ated with each of these categories. The first box gives the
distribution of genes in pathways appearing significant on
both platforms. The second box gives genes appearing sig-
nificant only in the sequencing platform (i.e. do not
appear anywhere on the list from the array platform) and
the third box is the length distribution of all the tran-
scripts in the analysis. It can be clearly seen that genes in
categories only over-represented on the RNA-seq platform
are significantly longer than average.
Discussion
Transcript length bias in RNA-seq data is a predictable
consequence of the sampling process and cannot be cor-
rected by dividing by length of the transcript (e.g. the sta-
tistical methods in Cloonan et al (2008) or Sultan et al.
Differential expression as a function of transcript length Figure 1
Differential expression as a function of transcript length. The data is binned according to transcript length and the per-
centage of transcripts called differentially expressed using a statistical cut-off is plotted (points). A linear regression is also plot-
ted (lines). a – e use all the data from RNA-seq and the microarrays from studies [4-6] respectively. f and g plot 33% of genes 
with highest expression levels (blue crosses) and 33% of genes with low expression (red triangles) taken from the microarray 
data for genes which appear on both platforms in [6]. The regression gives a significant trend for the percent of differential 
expression with transcript length for a, c, d and f and the lowly expressed genes in g. Note that this figure illustrates common 
data features between disparate experiments and is not a comparison between platforms, methods or experiments.Biology Direct 2009, 4:14 http://www.biology-direct.com/content/4/1/14
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(2008)). Length bias is expected for a Poisson random
variable, where the expected read count of a gene is pro-
portional to the length as well as expression level of a tran-
script. In other words, the sampling is higher for long
genes compared to short genes and therefore there is more
power to detect differential expression at a given statistical
significance regardless of the specific test used. Statistical
tests to detect differential expression between samples
require estimates of the mean and the variance of the sam-
ples. Dividing the mean by the length of the transcript
removes the bias from that measure but subsequently
introduces a length bias into the variance and the problem
still persists. Similarly, as with microarrays, there is more
power to detect differential expression for genes with
higher expression levels. However, we have not focused
on this phenomenon here as we feel that expression level
is a biologically meaningful quantity compared to tran-
script length bias, which is technical in nature.
Different processing methods can be used with high-
throughput sequencing to determine the levels of tran-
scription such as massively parallel signature sequencing
(MPSS), serial analysis of gene expression (SAGE), cap
analysis of gene expression (CAGE). These methods only
count one sequence per transcript hence will not suffer
from transcript length effects. However, in many cases
researchers will want to examine the full complexity of the
transcriptome by sequencing the entire RNA repertoire so
we speculate that these unbiased methods will make up a
small fraction of RNA-seq experiments. As fragment size is
the basis of transcript length bias rather than the number
of bases read, improvements in read length on the current
platforms will not alter transcript length bias.
Using exon level analysis as a way to reduce the range in
transcript lengths may not reduce the bias significantly.
Although the lengths of genes are obviously longer than
exons when looking at the length of genes and exons in
the human genome the interquartile range (IQR) in log2
length is similar (genes IQR = 1.45, exons IQR = 1.23).
This implies that the number of genes doubling in length
is similar to the number of exons doubling in length
meaning the bias is just as strong. Extending the sequenc-
ing depth will increase the ability to detect differential
expression. However as transcript length bias is a relative
measure between genes it will not affect the presented
results.
Currently the only method we suggest to account for
length bias between genes would be to use a fixed length
window approach, with a window size smaller than the
smallest gene. In this method aggregated tag counts for
each window could be calculated and assessed for differ-
ential expression. A further extension could combine mul-
tiple windows per transcript into a single measure in a way
similar to combining multiple probes in the RMA micro-
Mean-variance relationship Figure 2
Mean-variance relationship. Here we show the sample variance across lanes in the liver sample from the Marioni et al[6] 
data plotted as a function of the mean for each gene (a). Next we have the same data where the tag counts for each gene are 
divided by the length of the gene (b). The red line fits a linear relationship between the mean and variance for the one third of 
shortest genes while the blue line is the linear fit to the longest genes. In plot a the fits are very close to the line of equality 
between mean and variance (black line) which is what would be expected from a Poisson process. In plot b the short genes 
have higher variance for a given expression level than long genes.Biology Direct 2009, 4:14 http://www.biology-direct.com/content/4/1/14
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array algorithm [9] but this suggestion requires further
exploration and analysis. Nonetheless, as analysis needs
to be done at the window level this would require discard-
ing some proportion of the data or introducing a variable
number of windows per gene. Additionally the small size
of the windows will require a larger total number of reads
per sample to achieve statistical significance reducing
power to the equivalent level of small genes in a gene
focused analysis.
It is important to understand that using a statistical cut-off
to generate a list of DE genes from aggregated tag counts
inevitably will be more sensitive to genes with longer tran-
scripts. Hence gene sets and ontology classes containing
genes with different length distributions may look spuri-
ously under or over represented in gene set testing. As
gene set testing is an integral part of many systems biology
experiments and large biomedical projects such as the
International Cancer Genome Consortium, the length
bias will significantly impact many applications where
RNA-seq is currently being utilized. Sophisticated statisti-
cal methodology will be required to develop a new analy-
sis framework that gives similar false discovery rates for
different transcript lengths.
Conclusion
The different strengths of the currently available RNA-seq
and microarray technologies make these platforms com-
plementary for comprehensive analysis of the transcrip-
tome. A technical feature of using high-throughput
sequencing to interrogate full length transcripts is that
longer transcripts produce more reads relative to short
transcripts of similar expression. This higher sampling
means that there is more statistical power to detect differ-
ential expression for long transcripts compared to short
ones. Using three published RNA-seq data sets we have
demonstrated that, as we hypothesized, longer transcripts
have more power to detect differential expression. These
data sets each use different samples, platforms and statis-
tical methods. This bias does not exist in microarray data.
If unaccounted for, transcript length bias in the ability to
detect differential expression can confound system biol-
ogy and gene set testing approaches. Understanding tech-
nical issues in new technologies will lead to the
Table 1: Overrepresented KEGG pathways using microarrays.
Term Count Pop Hits PValue Benjamini
hsa04610:Complement and coagulation cascades 54 68 2.36E-10 5.44E-08
hsa00980:Metabolism of xenobiotics by cytochrome P450 45 65 6.97E-06 5.37E-04
hsa00190:Oxidative phosphorylation 74 121 5.83E-06 6.73E-04
hsa00120:Bile acid biosynthesis 25 36 0.00126 0.0702
hsa00260:Glycine, serine and threonine metabolism 29 45 0.00246 0.107
hsa00591:Linoleic acid metabolism 20 31 0.01496 0.252
hsa00380:Tryptophan metabolism 35 60 0.00764 0.255
hsa05010:Alzheimer's disease 19 29 0.0149 0.271
hsa00363:Bisphenol A degradation 11 14 0.0188 0.287
hsa00020:Citrate cycle (TCA cycle) 18 27 0.0148 0.291
hsa04514:Cell adhesion molecules (CAMs) 65 126 0.0108 0.300
hsa00040:Pentose and glucuronate interconversions 16 23 0.0141 0.305
hsa03320:PPAR signaling pathway 39 70 0.0125 0.305
hsa00650:Butanoate metabolism 26 45 0.0280 0.374
hsa00280:Valine, leucine and isoleucine degradation 25 44 0.03995 0.425
hsa00361:gamma-Hexachlorocyclohexane degradation 15 23 0.0379 0.428
hsa00903:Limonene and pinene degradation 18 29 0.0360 0.432
hsa00230:Purine metabolism 69 143 0.0472 0.462
hsa00071:Fatty acid metabolism 25 45 0.0536 0.488
hsa00670:One carbon pool by folate 11 16 0.0622 0.524
hsa00620:Pyruvate metabolism 23 42 0.0776 0.526
hsa00910:Nitrogen metabolism 14 23 0.0874 0.529
hsa00010:Glycolysis/Gluconeogenesis 31 59 0.0666 0.531
hsa04330:Notch signaling pathway 25 46 0.0703 0.535
hsa00860:Porphyrin and chlorophyll metabolism 21 38 0.0857 0.535
hsa02010:ABC transporters – General 24 44 0.0738 0.537
hsa00150:Androgen and estrogen metabolism 28 53 0.0774 0.539
hsa00410:beta-Alanine metabolism 15 25 0.0838 0.541
hsa00052:Galactose metabolism 18 32 0.0996 0.554
hsa04614:Renin-angiotensin system 11 17 0.0977 0.559
Categories in bold are not found to be overrepresented in the RNA-seq data.Biology Direct 2009, 4:14 http://www.biology-direct.com/content/4/1/14
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development of more sophisticated analysis methodolo-
gies.
Methods
Here we show, under some very simple assumptions, that
when testing for differences between two samples for a
given expression level, a longer gene will be more signifi-
cant that a shorter gene. Let X be the measured number of
reads in a library mapping to a specific transcript. The
expected value of X is proportional to the total number of
transcripts N times the length of the gene L
where c is a proportionality constant. Assuming the data
is distributed as a Poisson random variable, the variance
is equal to the mean.
m == EX c N L ()
Var X cNL () == m
Table 2: Over represented KEGG pathways using Illumina sequencing.
Term Count Pop Hits PValue Benjamini
hsa04610:Complement and coagulation cascades 60 68 3.08E-08 7.11E-06
hsa04910:Insulin signaling pathway 96 133 1.06E-04 0.0122
hsa00020:Citrate cycle (TCA cycle) 25 27 2.23E-04 0.0170
hsa00120:Bile acid biosynthesis 31 36 4.23E-04 0.0242
hsa00071:Fatty acid metabolism 37 45 5.35E-04 0.0244
hsa00980:Metabolism of xenobiotics by cytochrome P450 50 65 7.29E-04 0.0277
hsa00190:Oxidative phosphorylation 85 121 0.001155 0.0374
hsa00310:Lysine degradation 38 48 0.001627 0.0459
hsa04510:Focal adhesion 128 196 0.004824 0.0966
hsa00051:Fructose and mannose metabolism 33 42 0.00463 0.102
hsa00650:Butanoate metabolism 35 45 0.00448 0.109
hsa04520:Adherens junction 52 74 0.0129 0.171
hsa04810:Regulation of actin cytoskeleton 133 208 0.0116 0.175
hsa04912:GnRH signaling pathway 64 93 0.0109 0.177
hsa00010:Glycolysis/Gluconeogenesis 43 59 0.0110 0.177
hsa00230:Purine metabolism 94 143 0.0128 0.180
hsa00280:Valine, leucine and isoleucine degradation 33 44 0.0147 0.183
hsa05010:Alzheimer's disease 23 29 0.0200 0.228
hsa00620:Pyruvate metabolism 31 42 0.0262 0.253
hsa05210:Colorectal cancer 57 84 0.0250 0.254
hsa00260:Glycine, serine and threonine metabolism 33 45 0.0241 0.256
hsa04514:Cell adhesion molecules (CAMs) 82 126 0.0285 0.262
hsa04670:Leukocyte transendothelial migration 74 113 0.0315 0.275
hsa00220:Urea cycle and metabolism of amino groups 23 30 0.0359 0.297
hsa04360:Axon guidance 81 126 0.0429 0.313
hsa04370:VEGF signaling pathway 47 69 0.0401 0.315
hsa05120:Epithelial cell signaling in Helicobacter pylori infection 47 69 0.0401 0.315
hsa00052:Galactose metabolism 24 32 0.0448 0.315
hsa00480:Glutathione metabolism 27 37 0.0495 0.315
hsa00903:Limonene and pinene degradation 22 29 0.0488 0.319
hsa05040:Huntington's disease 22 29 0.0488 0.319
hsa03320:PPAR signaling pathway 47 70 0.0549 0.327
hsa00380:Tryptophan metabolism 41 60 0.0535 0.328
hsa05211:Renal cell carcinoma 45 67 0.0605 0.330
hsa00591:Linoleic acid metabolism 23 31 0.0596 0.333
hsa01510:Neurodegenerative Diseases 28 39 0.0585 0.336
hsa00410:beta-Alanine metabolism 19 25 0.0717 0.356
hsa00363:Bisphenol A degradation 12 14 0.0691 0.360
hsa00640:Propanoate metabolism 24 33 0.0712 0.361
hsa00860:Porphyrin and chlorophyll metabolism 27 38 0.0752 0.363
hsa00740:Riboflavin metabolism 13 16 0.0932 0.424
sa00770:Pantothenate and CoA biosynthesis 13 16 0.0932 0.424
hsa04530:Tight junction 81 130 0.0991 0.429
Categories in bold are not found to be over represented in the microarray data.Biology Direct 2009, 4:14 http://www.biology-direct.com/content/4/1/14
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As an example, we could test if the difference in counts
from a particular gene between two samples of the same
library size is significantly different from zero using a t-test
where D is the difference in the observed means from two
samples and S.E.(D) is the standard error of D.
The power of the t-test depends on E(D)/S.E.(D) = δ
which is essentially the non-centrality parameter of the t-
distribution
t
D
SE D
=
.. ( )
(1)
DX X
SE D c N L c N L
=−
=+
12
12 .. ( )
d =
−
+
∝
cN L cN L
cN L cN L
L 12
12
.
Length of genes found in KEGG pathways significantly over represented with differentially expressed genes Figure 3
Length of genes found in KEGG pathways significantly over represented with differentially expressed genes. 
The first box in the plot represents the length of genes found in the four significant categories from both platforms. The second 
box is the length of genes found in categories significant only in the sequencing data. The third box is the length of all genes in 
common to both technologies. It can be seen that categories unique to the sequencing data tend to have longer transcripts.Biology Direct 2009, 4:14 http://www.biology-direct.com/content/4/1/14
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It can be seen that this is proportional to the square root
of the length. Therefore for a given expression level the
test becomes more significant for longer transcript
lengths.
Dividing by gene length
Given the simple set-up above we can see the effect of
dividing expression levels by the length of the gene. Here
and
Given that we assumed that X was distributed as Poisson
random variable we can see that once we divide by length
the distribution is no longer Poisson and μ' ≠ Var(μ').
Using the same format of the t-test above we see that we
recover the same length dependence as in equation 1.
where
Again the power of the t-test depends on E(D)/S.E.(D) = δ
where
We end up with the same test result as equation 1 which
still has a square root L dependence.
Empirical data
Processed data was downloaded for each of the three stud-
ies presented. Each data set contained a gene ID and the
results of a statistical test for differential expression
between samples. Each data set uses a different statistical
test. Briefly: Marioni et al. [6] modeled their 32 bp reads
from the Illumina Genome Analyzer using a Poisson
model based on the aggregated tag counts for each gene.
A likelihood ratio test was then used to test for significant
differences between samples. Cloonan et al. [5] generated
tags of 25–35 bp from a SOLiD sequencing machine. The
aggregated tag counts for each transcript were divided by
the length of the transcript. The data was then quantile
normalized and log2-transformed. Differential expression
was then assessed using an empirical Bayes moderated t-
test [10]. Illumina sequencing data of 27 bp read length
was generated by Sultan et al. [4] Aggregated tag counts for
each gene were divided by the number of unique 27-mers
found in the transcript. They then used a method based
on the proportion of counts from each library proposed
by Audic and Claverie [11] to determine the significant of
differential expression.
Transcript lengths for all human transcripts and mouse
transcripts were downloaded using BioMart and the
length of a gene was calculated as the median length of all
transcripts relating to that gene. Each gene was then
defined to be either differentially expressed or not differ-
entially expressed based on an arbitrary statistical cut-off.
Varying this cut-off made no qualitative difference to the
results. For the data from Marioni et al (2008) genes were
matched between the RNA-seq platform and the microar-
ray platform. These genes were then divided into three
equally sized groups based on the average log2 expression
level of the six microarrays in their study. The high expres-
sion and low expression groups were used in figures 1f
and 1g.
Abbreviations
DE: Differential expression; IQR: interquartile range.
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Reviewers' comments
Reviewers report 1
Rohan Williams, John Curtin School of Medical Research, Australian 
National University, Australia. Nominated by Gavin Huttley
RNA-Seq and related high-throughput sequencing are
receiving intense attention due to their potential to survey
the transcriptome in an unbiased, global fashion. While it
is likely that these sequencing based approaches will per-
mit a major advance on microarray based technologies, it
is also highly likely that unanticipated systematic errors
will be present in these data and will need to be corrected
in order to permit appropriate application. While expres-
sion microarrays and tiling arrays are known to be subject
to a number of such effects, to date there has been little
investigation of issues in the emerging RNA-Seq literature.
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Oshlack and Wakefield now present a re-analysis of data
from several recent RNA-Seq studies to show that identifi-
cation of differential expression is positively biased
towards longer transcripts (and has the potential to
impact downstream interpretation at a functional level).
Although it is recognised that tag count will be propor-
tional to the product of expression level and transcript
length, adjusting for transcript length does not remove
this effect: the authors show the effect arises from
increased variance for shorted transcripts. They further
argue that this effect is unlikely to be removed by exon-
level analysis. Interestingly, this effect is not observable in
microarray expression platforms. This paper represents an
important contribution to the ongoing development of
analysis methodology for RNA-Seq and I recommend it
for publication in Biology Direct.
Reviewers report 2
Nicole Cloonan, Institute for Molecular Bioscience, The University of 
Queensland, Australia. Nominated by Mark Ragan
In this paper, the authors describe "transcript length bias"
in RNAseq data, which is the reduced statistical power to
detect differential gene expression of short mRNAs when
compared to long mRNAs using a "shotgun sequencing"
approach. As randomly fragmented mRNA molecules will
generate less short-read tags for a short transcript than for
a longer transcript, changes in expression between two
(relatively) poorly sampled transcripts are less discernible
from sampling noise. The authors examine three pub-
lished shotgun sequencing-based studies to show this bias
exists in the sequencing data, but not in the corresponding
microarray data from the same samples. This bias against
short transcripts could lead to a general under-representa-
tion in gene set testing for functional categories enriched
in short genes (such as cell-cell communication, innate
immunity, and signal transduction). This is an important
finding that the RNA sequencing community needs to be
aware of.
The manuscript is generally well written, and the authors
have done well to create a manuscript understandable to
a biological audience without specialized mathematical
or statistical training. As all of my (generally minor) con-
cerns with this manuscript have been adequately
addressed, I recommend this manuscript for publication.
Reviewers Report 3
James Bullard, Division of Biostatistics, School of Public Health, 
University of California, Berkeley, USA. Nominated by Sandrine 
Dudoit
In Oshlack and Wakefield the authors demonstrate a rela-
tionship between gene-length and observed significance
of a statistical test in three published studies (Marioni et
al., Cloonan et al., Sultan et al.). The authors demonstrate
that this observed tendency is not present in the analysis
of the same samples in the Marioni study when microar-
rays are used. This "bias" is due to the dependence of the
variance on the intensity of the read-process which is pro-
portional to the length of the transcript sequenced.
The reviewer recommends the article for publication as
the issues presented are both relevantand important. In
particular, the issues presented are quite pertinent with
the advent of numerous high-throughput sequencing
studies. The reviewer believes that in its current form the
article would benefit from some revisions to either more
rigorously present the mathematics or simply present the
statistics described in the offending studies.
Background: paragraph 2, "We hypothesize ..." Why are
you hypothesizing? I think that this sentence needs refer-
ence to a particular test-statistic, then you really don't
need to hypothesize anything.
Author's response: We believe the statement in the article
relates to all statistical analysis methods under the assumptions
we have stated however we have not and really cannot test all
possible methods. Therefore we have used the word hypothesize
but we have also given an example in the methods section.
Background: paragraph 3, "All methods for detection of
..." Doesn't this sentence appear a bit strong?
Author's response: We amended this to "Most statistical meth-
ods..."
Results: paragraph 2, Can you comment why the "length
bias" is stronger for more lowly expressed genes? Also, I
think it is better to present all of the data on the plots,
rather than excluding the middle bin.
Author's response: We have added the sentence: "We believe
the slope is lower in highly expressed genes due to the observa-
tion that nearly all of these genes have enough power to be
called differentially expressed in this data set even though the
p-values are higher for shorter genes."
Results: paragraph 3, In the mean-variance plots how do
you compute the variance? Is this just the sample vari-
ance? What about the different numbers of counts across
lanes? As for panel (2), After we divide by length we don't
have a Poisson so the mean-variance plot is not correct or
at least the proper interpretation of it is non-obvious (isn't
it obvious that we will cause a shift on the plot because we
are now scaling by length squared?)
Author's response: Yes this is exactly the point we are trying to
make. This plot is meant to be more heuristic in nature rather
than any rigorous proof that dividing by length doesn't remove
the length bias. Therefore we have just used the sample variancePublish with BioMed Central    and   every 
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without taking into account the different number of counts
across lanes as a visual demonstration. To clarify we have also
added the sentence: "However, when the mean is divided by the
length of the transcript the relationship becomes more complex
and the data is obviously no longer Poisson"
Results: paragraph 4, A potentially "better" plot would be
boxplots (of gene-length) ordered from largest to smallest
KEGG p-value; both for microarray and sequencing data.
Author's response: Thank you for the suggestion. We felt that
the plot you suggested was a little bit more tricky to interpret.
Methods: paragraph 1, The math is a little sloppy. In gen-
eral, there is confusion between random variables and
parameters. Specifically, I note two obvious errors: 1.) t is
defined to be one thing (random variables on the rhs of
equation (1)) and then redefined to be another thing
(parameters on rhs of following definition). 2.) Methods:
paragraph 2, μ' is a parameter then you do the Var(μ')
which is incorrect, you probably want to dene an X'
instead, then you can take variances.
Author's response: Thanks for pointing this out. We have mod-
ified and tidied up the math.
From your treatment it appears that I can just divide t by
√ L to remove the dependence on L in the test-statistic is
this correct?
Author's response: No, I don't think this is possible. A t-test is
like a signal to noise ratio and therefore has a specific relation-
ship between the estimate of the mean and the standard error
of the estimate. I don't believe this should be broken by essen-
tially dividing the estimate of the mean by √ L.
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